France· FR:60286556
BIOCIDAN 0,1 mg/0,4 ml, collyre en récipient unidose
A cethexonium product containing bromure de céthexonium, registered in France by MENARINI FRANCE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BROMURE DE CÉTHEXONIUM
- Manufacturer
- MENARINI FRANCE
- Country
- France (FR)
- ATC code
- S01AX26
- ATC class
- Cethexonium
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093383496810 récipient(s) unidose(s) polyéthylène de 0,4 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01AX26
Cethexonium, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad12a7db-d841-466a-a519-7ff062904e0c GET /v1/drugs/ad12a7db-d841-466a-a519-7ff062904e0c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60286556",
"date_amm": "1994-12-21",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BROMURE DE CÉTHEXONIUM",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cethexonium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.